MiniMed Group, Inc. (MMED): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
MiniMed Group, Inc. (MMED) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 MiniMed Completes Separation from Medtronic NORTHRIDGE, Calif., October 15, 2026 – MiniMed (Nasdaq: MMED) today announced the completion of its separation from Medtronic plc (“Medtronic”; NYSE: MDT), marking its first day as a fully independent company. “Today marks
How this was made
The 30-second read
Why it matters
The creation of a new publicly traded entity provides a fresh investment opportunity and may trigger re‑rating by analysts.
Market read
The spin‑off is a primary corporate action that introduces a new ticker (MMED) to the market, likely generating short‑term trading interest.
What to watch
Potential regulatory approvals for MiniMed's products and integration costs of independent operations.
Background
MiniMed announced the completion of its separation from Medtronic, exchanging Medtronic shares for MiniMed shares and ending Medtronic's equity stake.
Ticker impact
MiniMed completed its separation from Medtronic, becoming a fully independent Nasdaq‑listed company.
expected pressure and volatility as the market assesses the standalone valuation; possible upside if investors view the spin‑off favorably
First disclosure of the separation; no prior market pricing for MMED as an independent stock.
Market effects
May affect other diabetes‑care and medical‑device stocks as investors compare standalone prospects.
Primarily U.S. market impact; limited regional effect.
Low global relevance beyond the healthcare sector.
Counterpoint
If the spin‑off loses synergies with Medtronic, the standalone valuation could be pressured.
Key entities
- CompanyMiniMed Group, Inc.
Newly independent diabetes‑care company.
- CompanyMedtronic plc
Former parent, no longer holds equity in MiniMed.
